Goldberg AC - Search Results

1

Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.

Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB; Ezetimibe Study Group. Goldberg AC, et al. Mayo Clin Proc. 2004 May;79(5):620-9. doi: 10.4065/79.5.620. Mayo Clin Proc. 2004. PMID: 15132403 Clinical Trial.

2

Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia.

Bradford RH, Goldberg AC, Schonfeld G, Knopp RH. Bradford RH, et al. Among authors: goldberg ac. Atherosclerosis. 1992 Jan;92(1):31-40. doi: 10.1016/0021-9150(92)90007-4. Atherosclerosis. 1992. PMID: 1575820 Clinical Trial.

3

Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.

Goldberg AC, Schonfeld G, Feldman EB, Ginsberg HN, Hunninghake DB, Insull W Jr, Knopp RH, Kwiterovich PO, Mellies MJ, Pickering J, et al. Goldberg AC, et al. Clin Ther. 1989;11(1):69-83. Clin Ther. 1989. PMID: 2655907 Clinical Trial.

4

The impact of lipid lowering in coronary artery disease.

Goldberg AC. Goldberg AC. Curr Opin Cardiol. 1997 Sep;12(5):488-93. Curr Opin Cardiol. 1997. PMID: 9352177 Review.

5

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

Knopp RH, Alagona P, Davidson M, Goldberg AC, Kafonek SD, Kashyap M, Sprecher D, Superko HR, Jenkins S, Marcovina S. Knopp RH, et al. Among authors: goldberg ac. Metabolism. 1998 Sep;47(9):1097-104. doi: 10.1016/s0026-0495(98)90284-0. Metabolism. 1998. PMID: 9751239 Clinical Trial.

6

Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia.

Goldberg A, Alagona P Jr, Capuzzi DM, Guyton J, Morgan JM, Rodgers J, Sachson R, Samuel P. Goldberg A, et al. Am J Cardiol. 2000 May 1;85(9):1100-5. doi: 10.1016/s0002-9149(00)00703-7. Am J Cardiol. 2000. PMID: 10781759 Clinical Trial.

7

Clinical implications of statin event trials.

Goldberg AC. Goldberg AC. Curr Atheroscler Rep. 2002 Sep;4(5):337-42. doi: 10.1007/s11883-002-0070-y. Curr Atheroscler Rep. 2002. PMID: 12162932

8

A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women.

Goldberg AC. Goldberg AC. Am J Cardiol. 2004 Jul 1;94(1):121-4. doi: 10.1016/j.amjcard.2004.03.042. Am J Cardiol. 2004. PMID: 15219522

9

Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs.

Goldberg AC, Ostlund RE Jr, Bateman JH, Schimmoeller L, McPherson TB, Spilburg CA. Goldberg AC, et al. Am J Cardiol. 2006 Feb 1;97(3):376-9. doi: 10.1016/j.amjcard.2005.08.056. Am J Cardiol. 2006. PMID: 16442399 Clinical Trial.

10

Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.

Goldberg AC, Bays HE, Ballantyne CM, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC. Goldberg AC, et al. Am J Cardiol. 2009 Feb 15;103(4):515-22. doi: 10.1016/j.amjcard.2008.10.025. Epub 2008 Dec 26. Am J Cardiol. 2009. PMID: 19195513 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters